BR112018013689A2 - composição estável e palatável de comprimidos de pastilha em forma de losango de vitamina c e zinco - Google Patents

composição estável e palatável de comprimidos de pastilha em forma de losango de vitamina c e zinco

Info

Publication number
BR112018013689A2
BR112018013689A2 BR112018013689-1A BR112018013689A BR112018013689A2 BR 112018013689 A2 BR112018013689 A2 BR 112018013689A2 BR 112018013689 A BR112018013689 A BR 112018013689A BR 112018013689 A2 BR112018013689 A2 BR 112018013689A2
Authority
BR
Brazil
Prior art keywords
vitamin
stable
zinc
palatable composition
lozenge tablets
Prior art date
Application number
BR112018013689-1A
Other languages
English (en)
Portuguese (pt)
Inventor
U. Dee Kennie
G. Mendoza Wendell
Josefina M. Santos Rita
Original Assignee
Novex Science Pte Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novex Science Pte Limited filed Critical Novex Science Pte Limited
Publication of BR112018013689A2 publication Critical patent/BR112018013689A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112018013689-1A 2016-01-15 2016-01-15 composição estável e palatável de comprimidos de pastilha em forma de losango de vitamina c e zinco BR112018013689A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PH2016/000001 WO2017123103A1 (en) 2016-01-15 2016-01-15 Stable and palatable composition of vitamin c and zinc lozenge tablets

Publications (1)

Publication Number Publication Date
BR112018013689A2 true BR112018013689A2 (pt) 2019-04-30

Family

ID=59311387

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018013689-1A BR112018013689A2 (pt) 2016-01-15 2016-01-15 composição estável e palatável de comprimidos de pastilha em forma de losango de vitamina c e zinco

Country Status (9)

Country Link
KR (1) KR20180101530A (zh)
CN (1) CN108495621A (zh)
AU (1) AU2016386385B2 (zh)
BR (1) BR112018013689A2 (zh)
HK (1) HK1256968A1 (zh)
NZ (1) NZ744260A (zh)
PH (1) PH12018501438A1 (zh)
SG (1) SG11201805821UA (zh)
WO (1) WO2017123103A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108347990A (zh) * 2015-10-16 2018-07-31 诺维克斯科学私人有限公司 维生素c和锌片剂的稳定组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316008B1 (en) * 1998-09-03 2001-11-13 John C. Godfrey Combination of zinc ions and vitamin C and method of making
FR2883182B1 (fr) * 2005-03-16 2008-02-15 Novartis Ag Composition de vitamines utiles dans le traitement des maladies oculaires
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
CA2750216A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same

Also Published As

Publication number Publication date
PH12018501438A1 (en) 2018-11-05
AU2016386385A1 (en) 2018-07-26
KR20180101530A (ko) 2018-09-12
AU2016386385B2 (en) 2020-05-21
HK1256968A1 (zh) 2019-10-04
CN108495621A (zh) 2018-09-04
SG11201805821UA (en) 2018-08-30
WO2017123103A1 (en) 2017-07-20
WO2017123103A8 (en) 2018-07-26
NZ744260A (en) 2020-07-31

Similar Documents

Publication Publication Date Title
GT201600249A (es) Nuevos derivados de pirazolo pirimidina y su uso como inhibidores de malt1
MX2022011225A (es) Formulaciones farmaceuticas de un inhibidor de hidroxilasa de hif.
PH12016501236A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
EA201890828A1 (ru) Оптимизированная таблетка с высокой дозой активного соединения, содержащая месалазин
PH12017501692A1 (en) Solid forms of menaquinols
PH12018500791A1 (en) Stable composition of vitamin c and zinc tablet
DOP2015000296A (es) Formulacion oral para el tratamiento de enfermedades cardiovasculares
FR2991175B1 (fr) Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide
BR112018013689A2 (pt) composição estável e palatável de comprimidos de pastilha em forma de losango de vitamina c e zinco
MX2015016490A (es) Esteres sulfatados de acidos oligohidroxicarboxilicos, y uso de los mismos.
EA201591860A1 (ru) Усилители водорастворимости на основе гликогена
UY34595A (es) Composición farmacéutica de liberación prolongada de trimetazidina
BR112019023437A2 (pt) Partículas sólidas
PH12016501245A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
MX2016008225A (es) Composiciones para cuidado oral y metodos.
UA77230U (ru) «ампролев» Комплексный препарат для лечения гетеракозно-гистомонозной инвазии птицы
CU20150043A7 (es) Inhibidores de la tirosina-quinasa de bruton
UA107884C2 (en) Combined anti-tuberculosis drug
RU2013117289A (ru) Применение воды и водосодержащих сред с отрицательным окислительно-восстановительным потенциалом меньше ноля в качестве основы или растворителя для медикаментозных, гомеопатических препаратов и биологически активных добавок
TH148819B (th) สารควบคุมการเกิดเมลานิน
UA89422U (ru) Способ изготовления дезинфектанта пролонгированного действия для стерилизации поверхностей
RO130486A8 (ro) Formulă farmaceutică pentru comprimate masticabile mentolate cu calciu şi vitamina d3
UA92875U (uk) Спосіб профілактики серцево-судинних захворювань

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2757 DE 07-11-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.